Keybanc analyst Sophie Karp downgrades Exelon (NASDAQ:EXC) from Overweight to Sector Weight.
Stifel Maintains Buy on IBM, Lowers Price Target to $140
Stifel analyst David Grossman maintains IBM (NYSE:IBM) with a Buy and lowers the price target from $150 to $140.